Acceder

K-V Pharmaceutical Co. Opiniones

2,2K respuestas
K-V Pharmaceutical Co. Opiniones
K-V Pharmaceutical Co. Opiniones
Página
207 / 277
#1649

Re: K-V Pharmaceutical Co. Opiniones

News Highlights: Top Equities Stories Of The Day

Date :

08/14/2013 @ 1:15PM

Source :

Dow Jones News

News Highlights: Top Equities Stories Of The Day

Print


TOP STORIES

U.S. CHARGES TWO EX-J.P. MORGAN TRADERS
Criminal charges were filed against two former J.P. Morgan Chase traders who were at the center of a series of bad bets that cost the nation's largest bank more than $6 billion in losses.

U.S. STOCKS DRIFT LOWER ON CONCERN OVER OUTLOOK

U.S. stocks have turned lower in light trading, amid growing investor caution about the outlook for the rest of the year. The DJIA is down about 70 points.

U.S. JULY PRODUCER PRICES UNCHANGED

The producer price index was unchanged last month after rising 0.8% in June. Core prices, which exclude volatile food and energy costs, rose 0.1% in July. Economists had forecast a 0.3% gain in overall prices and a 0.2% rise in core prices.

MACY'S CUTS YEAR VIEW AMID SOFT SALES

Macy's second-quarter profit edged up 0.7% to $281 million, or 72c a share, although the department-store chain reported softer-than-expected sales amid what it called consumer uncertainty. Shares fall 4%.

EGYPTIAN TROOPS IN DEADLY CRACKDOWN ON PROTESTERS

Egypt's efforts to end Muslim Brotherhood protests turned deadly, with at least 95 people killed across the country in violence that was sparked when police, later backed by Egyptian soldiers, moved to clear two antigovernment sit-ins in Cairo.

U.S. HOUSEHOLD DEBT AT LOWEST LEVEL SINCE 2006

Total U.S. household debt, including mortgages, credit cards and auto loans, fell by $78 billion in the second quarter to $11.15 trillion, the lowest level since 2006, according to a report by the Federal Reserve Bank of New York.

DEERE PROFIT UP AS FARM EQUIPMENT SALES GROW

Deere's fiscal 3Q earnings rose 26% to $996.5 million, or $2.56 a share, amid continued growth of farm-equipment sales in the U.S. and Canada. Total revenue, which includes Deere's financing unit, increased 4.4% to $10.01 billion.

AIG SETS DEADLINE ON JET LEASING UNIT SALE

AIG has set an internal deadline of September for a Chinese consortium to come up with the money to close the delayed $4.7 billion sale of AIG's aircraft-leasing unit, according to a person with knowledge of the situation.

STARBOARD SHOOTS DOWN LATEST OFFICE DEPOT OFFER

Dissident shareholder Starboard Value shot down Office Depot's offer to seat its board nominees, calling it a "flawed and unprofessional" effort to sidestep a dialogue.

GOVERNMENT WATCHDOG OBJECTS TO KODAK PLAN

The government's bankruptcy watchdog is objecting to Eastman Kodak's plan to exit bankruptcy because it tries to throw in illegal bonuses for company insiders, including a so-called emergence award of $1.9 million earmarked for Chief Executive Antonio Perez.

GROSS SEES 80% CHANCE OF FED TAPERING NEXT MONTH

Bill Gross, founder and co-chief investment officer at Pacific Investment Management Co., said in a televised interview that there's an 80% chance the Federal Reserve will begin to taper its asset purchases in September




======= DOW JONES NEWSWIRES ANALYSIS AND COMMENTARIES =======


Analysis
EURO-ZONE RECOVERY MAY BE TOO SLOW

Most economists say the euro zone's recovery is too sluggish to overcome the deep problems ailing the bloc any time soon, including mass unemployment, rising debts, sick banks and fraying politics, writes Marcus Walker.

FX Horizons
EMPTY PROMISES PUT CENTRAL BANKS DEEPER IN MARKET'S THRALL

Both investors and central bankers believe there really is some value in the new "state-dependent" communication policy, and that is making each side's interests even more tightly--and unhealthily--intertwined.


Bookmark With :

#1650

Re: K-V Pharmaceutical Co. Opiniones

ya se opusieron a plan de bancarotade kodak ahora esto debe pesar el kv tambien mismos involucrados

12-13346-alg K-V Discovery Solutions, Inc., et al. Cap. 11

Movimiento aprobar y autorizar el establecimiento con Gedeon Richter PLC y Gedeon Richter USA

*** DE CALENDARIO ***



Adversario proceder: 12-02005-alg de Estados Unidos de América v. compañía farmacéutica K-V
Conferencia previa al juicio
Aplazada RESET para 11/09/2013 en 11:00


12-13346-alg K-V Discovery Solutions, Inc., et al. Cap. 11

Cuarta objeción omnibus buscan reclasificar determinadas pruebas de reclamación; reducir y permitir ciertas reclamaciones exageradas. (reclamación de 197)
Aplazada RESET para 11/09/2013 en 11:00


Tercera objeción omnibus a la asignación de ciertas reclamaciones (ninguna responsabilidad, pagado y reclamaciones no deudor) (reclamación Nº 89, 272, 319, 95, 360, 361 y 50)

Respuestas presentadas.
Aplazada RESET para 11/09/2013 en 11:00


Movimiento por Deutsche Bank Trust Company Americas, como fideicomisario, dirigir la examinación de la compañía farmacéutica K-V, Thompson Coburn LLP y Cleary Gottlieb Steen & Hamilton LLP

Acumulación de la oficial Comisión de acreedores a la moción presentada.
Aplazada RESET para 11/09/2013 en 11:00



#1651

Re: K-V Pharmaceutical Co. Opiniones

vean mi post anterior aplasado al 11 de septiembre muy bueno ganamos tiempo
quisas el11 de septiembre lo hasen feriado por las torres gemelas y aplasan mas

#1652

Re: K-V Pharmaceutical Co. Opiniones

12-13346-alg K-V Discovery Solutions, Inc., et al. Cap. 11

Adversario proceder: 13-01381-alg Silver Point Finance, LLC et al v. Deutsche Bank Trust Company Americas, únicamente como Tr
Ensayo RE: disputa hechos.

#1653

Re: K-V Pharmaceutical Co. Opiniones

audiencia para el 28 de agosto pedir ampliar periodo de chapter 11

11:00

12-13346-alg K-V Discovery Solutions, Inc., et al. Cap. 11

Audiencia de confirmación.



Moción para extender el período de exclusividad para la presentación de un Plan de capítulo 11 y declaración de divulgación / deudores del movimiento para más extensión exclusiva períodos de orden archivo Plan de reorganización y solicitar las aceptaciones mismos conforme a la sección 1121(d) del código de bancarrota [documentos relacionados 381, 587, 930]




#1654

Re: K-V Pharmaceutical Co. Opiniones

es bueno desde el punto de vista de que cuanto mas tiempo pase, mejores serán los números para que el juez dicte, además de la esperada votación del senado, que parece ser el próximo hito más cercano. Ahora bien, quizá los inversores salgan esperando volver más adelante, ya que el tiempo se ha prolongado y nadie quiere tener el dinero retenido en un movimiento lateral.

a ver como se lo toma el señor mercado

#1655

Re: K-V Pharmaceutical Co. Opiniones

Esta se va al 0,14 de cabeza

#1656

Re: K-V Pharmaceutical Co. Opiniones

hoy note en la mañana apertura caida libre de cerp kodak un poco kv fnma caida libre y american caida me parese una manipulacion generalizadaa la baja recuperaran al mismo ritmo la mayoria

Te puede interesar...
  1. Inflación y tipos en el punto de mira, la historia no se repite pero rima
  2. La Euforia Post-Trump: ¿Calma o Tormenta en el Mercado?